2018. SIGNALLING PATHWAYS AND MOLECULAR TARGETS FOR SKIN CANCER: INVOLVEMENT OF CDK2 INHIBITION. Nirma University Journal of Pharmaceutical Sciences. 5, 1 (Jun. 2018), 41–58. DOI:https://doi.org/10.5281/.